Optimisation of the Manufacturing Process of Organic-Solvent-Free Omeprazole Enteric Pellets for the Paediatric Population: Full Factorial Design

dc.contributor.authorRouaz El Hajoui, Khadija
dc.contributor.authorGarcía Montoya, Encarna
dc.contributor.authorLópez Urbano, Andrea
dc.contributor.authorRomero Obon, Miquel
dc.contributor.authorChiclana Rodríguez, Blanca
dc.contributor.authorFraschi Nieto, Alex
dc.contributor.authorNardi Ricart, Anna
dc.contributor.authorSuñé Pou, Marc
dc.contributor.authorSuñé Negre, Josep María
dc.contributor.authorPérez Lozano, Pilar
dc.date.accessioned2024-01-09T10:56:29Z
dc.date.available2024-01-09T10:56:29Z
dc.date.issued2023-11-04
dc.date.updated2024-01-09T10:17:19Z
dc.description.abstractLiquid formulations are mostly used in the paediatric population. However, with certain active pharmaceutical ingredients (APIs), it is very difficult to guarantee quality and stability; this is the case, for example, with omeprazole. Omeprazole is used as a model drug due to the lack of a paediatric formulation meeting gastro-resistance requirements, which remains a challenge today. In this experimental study, the development of enteric polymer-coated pellets is proposed. It is proposed to use aqueous coating dispersions without the use of organic solvents, which are commonly used in fluidised bed coatings. To do this, the design of experiments method is used as a statistical tool for experiment creation and the subsequent analysis of the responses. In particular, this study uses a randomised full factorial design. The mean weight increases of the protective layer and the enteric coating are chosen as factors. Each factor is assigned two levels. Therefore, the design of the used experiments is a 22 + 1 central point. Overall, the obtained pellets can be an alternative to the compounding formulas of omeprazole that are currently used in the paediatric population, which do not meet the gastro-resistance specifications necessary to guarantee the therapeutic efficacy of this active ingredient.
dc.format.extent18 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1999-4923
dc.identifier.pmid38004567
dc.identifier.urihttps://hdl.handle.net/2445/205420
dc.language.isoeng
dc.publisherMDPI AG
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/pharmaceutics15112587
dc.relation.ispartofPharmaceutics, 2023, vol. 15, num. 11
dc.relation.urihttps://doi.org/10.3390/pharmaceutics15112587
dc.rightscc by (c) Rouaz El Hajoui, Khadija et al, 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationOmeprazol
dc.subject.classificationPediatria
dc.subject.otherOmeprazole
dc.subject.otherPediatrics
dc.titleOptimisation of the Manufacturing Process of Organic-Solvent-Free Omeprazole Enteric Pellets for the Paediatric Population: Full Factorial Design
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
pharmaceutics-15-02587-v2.pdf
Mida:
2.77 MB
Format:
Adobe Portable Document Format